420 with CNW — Biden’s Pick for Top FDA Job Has Prescribed Cannabis-Based Medicine

President Joseph Biden isn’t a big fan of broad, comprehensive cannabis reform. Even though plenty of Democrats and even some Republicans have thrown their weight behind broad legalization, Biden favors decriminalizing cannabis, legalizing medical cannabis, and giving states the freedom to craft their own marijuana policies. This has been a bone of contention for many lawmakers, especially those from the left, and Senate Majority Leader Chuck Schumer stated that he would advance broad federal legalization with or without the president. A recent move by Biden may be a sign of his preference for medical cannabis.

On Friday, Biden announced that he has nominated a new Food and Drug Administration (“FDA”) commissioner who, coincidentally, has acknowledged that cannabis has medical potential and has even prescribed a cannabinoid-based drug as a physician. A cardiologist by trade, Robert Califf served as the 22nd FDA commissioner from February 2016 to January 2017 after President Barack Obama nominated him in 2015. Prior to that, he had been serving as the deputy commissioner of the United States Food and Drug Administration’s Office of Medical Products and Tobacco. He was hired by Alphabet Inc. (Google’s parent company) in 2019 as the head of Medical Strategy and Policy.

Califf is a tenured professor of cardiology at the Duke University School of Medicine, and he is the founding director of what is said to be the largest academic research organization on the globe, the Duke Clinical Research Institute. While he hasn’t been very vocal about cannabis, he made his views on the subject known during a 2016 cannabis research summit hosted by the federal government. He acknowledged that the controversial plant has several medical applications and said that the FDA was interested in advancing cannabis research and development.

He mentioned the treatment of epilepsy, AIDS wasting, cancer, neuropathic pain, spasticity, multiple sclerosis, and cancer as well as chemotherapy-induced nausea as some of the possible uses of cannabis and cannabinoid-infused products. Furthermore, he stated that he had prescribed cannabis-related treatments to patients afflicted with wasting cachectic syndrome due to extreme heart failure in his cardiology practice. Even though the FDA may not have found that cannabis can be a safe and effective treatment, he said at the time thatit doesn’t mean the drug has zero good uses. Califf added that we need additional studies to learn more about marijuana’s possible risks and benefits.

In 2019, he authored an op-ed advocating for strict regulation of vapes and the ban of flavored vape products to reduce the risks of lung disease in the wake of the 2019 vape lung illness outbreak. He later said that an outright ban on all vape products would be impractical and that prohibition would perpetuate a stigma that would keep addicts from seeking treatment.  

If Califf takes office as FDA commissioner, there is hope that he will be less hostile to the products made by cannabis companies such as Hero Technologies Inc. (OTC: HENC) since he has some experience with the therapeutic potential of marijuana products.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How to Calculate THC Levels in Marijuana Edibles

THC, or delta-9 tetrahydrocannabinol, is the chemical agent responsible for marijuana’s psychoactive effects. When ingested, the effects of THC tend to be stronger and last longer, meaning any dosage mistakes can leave users feeling uncomfortably high for hours. In fact, many a first-time user has ingested too much THC and vowed never to consume cannabis again due to the intense and often uncomfortable experience.

So how exactly would you calculate THC levels in marijuana edibles at home without access to scientists and fancy machines?

The first thing you should do is find out the cannabinoid content in the cannabis flower you plan to use. This will include THCA, the precursor to THC. In cannabis flower, THCA usually converts to THC once the flower is combusted in a process called decarboxylation, but in the case of edibles, you will have to heat your flower in butter or high-quality oil. The amount of THC that will convert to THC is referred to as the decarb rate and will determine the final dosage of edibles. The recommended dose for beginners is one to five milligrams of THC with one equaling 1,000 milligrams. Once you’ve settled on a dose, it’s time to estimate the decarb rate.

Let’s assume 90% of the THCA in your flower will decarb into THC. The next step will be to estimate the extraction efficiency, meaning the amount of THC that will be extracted from the flower and infused into the oil or butter. Most experts set the average extraction efficiency at 30% to 40% but we’ll assume a 60% extraction efficiency to stay on the safe side.

Once you know how much THC your flower contains and you have the decarb rate and extraction efficiency down, you’ll have to do a little math. Presuming you use 10g of cannabis flower with 20% THC, giving you a total of 2,000mg THC, your formula would be 2,000mg x 0.9, or the amount of THC x decarb rate.

This would give you a THC yield of 1,800 mg, which you would then multiply by the extraction efficiency of 60%; 1,800 x 0.6 would result in oil or butter infused with 1,080mg of THC, enough for 216 5mg portions. Regardless of the decarb rate and extraction efficiency estimates you use, you should multiply the amount of cannabis by the decarb rate and then multiply the answer by the extraction efficiency rate. Do the math several times. Furthermore, make sure you mix the oil or butter thoroughly to ensure THC is evenly distributed.

Cannabis manufacturers such as Hero Technologies Inc. (OTC: HENC) often have edibles of varying potency, so it is good to acquaint yourself with a method to calculate how much THC is in each serving, especially if you are using cannabis for medicinal purposes.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Army Recruits with History of Cannabis Use Perform Like Other Soldiers

A new analysis funded by the government has found that past marijuana use has little to no effect on overall performance of army recruits. The analysis found that recruits who had a history of cannabis use were just as likely as their peers to advance in rank. They were also more likely to leave the army due to drug issues but less likely to leave as a result of performance or health issues. The analysis also found no evidence that the legalization trend spreading across the United States had affected recruit outcomes.

The report, which was compiled by the RAND Corporation, states that recruits with a documented history of behavioral health conditions or cannabis as well as waivered recruits were in some cases likely to perform better in comparison to their counterparts.

The report focuses on waivers that permit the U.S. Army to reconsider applicants who had initially been disqualified for a variety of reasons, including the use of marijuana. Applicants with a documented history of marijuana use as well as those who test positive for cannabis need waivers to enlist into the army. This also applies to individuals diagnosed with depression, anxiety disorders or ADHD.

In a blog post, an official from RAND Corp. stated that without the presence of waivers, about one-third of individuals aged 18 or older would be prevented from enlisting because of failed cannabis drug tests. The official noted that recruits who were allowed to join the army despite their history of cannabis use performed like other soldiers.

The Arroyo Center, a federally funded research and development center under RAND Corp, was asked by the U.S. Army to conduct an analysis of the performance of recruits who had received waivers. The analysis gathered records on every recruit who entered the U.S. Army between 2001 and 2012, with the researchers noting that the analysis didn’t find a statistically substantial relationship between the performance of a recruit and a documented history of marijuana use.

Overall, the researchers found that the performance of recruits wouldn’t change significantly if waivers were increased, noting that in some cases, the impact would be improvements in performance. Currently, those wishing to join the army have the option of requesting positive tests for cannabis during their physical exams. Applicants can also request waivers for misdemeanor convictions for driving while impaired or under the influence of cannabis and for the possession of paraphernalia or marijuana.

The authors of the report acknowledge that while some of their findings reinforced existing views, most differed from their expectations.

It looks as if science is gradually dispelling many of the misconceptions that have surrounded marijuana, and a time may come when sector players such as Hero Technologies Inc.(OTC: HENC) will operate in an environment that views cannabis just like any other commodity.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Hero Technologies Inc.’s (HENC) Cultivation Systems Producing High Plant Density with Minimal Environmental Impact

Hero Technologies (OTC: HENC) is committed to a strategic grow plan that produces high-efficiency, low-carbon-footprint crops. A recent Colorado State University (“CSU”) report observed that 80% of the one million pounds of marijuana grown annually in Colorado is produced indoors. Indoor cultivation requires energy intense grow lights, fans to circulate air and strengthen stems, carbon dioxide gas to increase plant growth, and sophisticated equipment to maintain a comfortable temperature and humidity. Considering that this energy primarily comes from fossil fuels, this form of artificial plant production may not be so environmentally friendly. “Hero Technologies cultivation systems, on the other hand, use a proprietary aeroponic cultivation system and high-tech sun chambers designed to produce high plant density and yields but with minimal environmental impact,” reads a recent article. According to HENC CEO Gina Serkasevich, the company anticipates that its systems could reduce operating costs by one-third or more. “In addition, we expect our cannabis cultivation technologies to produce optimal plant density and crop cycles for the lowest possible cost-per-yield, which is the biggest contributor to sustainability, efficiency and positive environmental impact.”

To view the full article, visit https://cnw.fm/VHR0i

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — Senate Committee Asks State Department to Account for Funds Spent on Drug War

A recent report filed by top senators has asked the State Department to explain how the billions in funding that was injected into various counter-narcotics programs across Latin America were used, as these programs haven’t yielded results. The report also calls out the federal government over the failed war on drugs.

The report is part of the bill to finance the federal government that Chairman Patrick Leahy of the Senate Appropriations Committee introduced a couple of days ago.

The panel stated that the incidence of corruption and violence related to drug trafficking in Latin America has increased steadily since the 1980s when various counter-narcotics programs were introduced. The use and availability of illicit drugs in the United States is also high. The panel noted that despite these failures, the strategies used by different U.S. administrations since the inception of these programs remain unchanged.

The report directs the secretary of state to compile and present a report that assesses the reasons why prior efforts haven’t met the expectations as well as the cost-benefit analysis of previous counter-narcotics initiatives in Mexico, Central America, Colombia, Bolivia and Peru.

The committee is also seeking a description of the objectives and projected results of the present strategy, how the present strategy is different from past efforts and any necessary changes in the United States domestic counter-narcotics policies. This, it stated, would allow strategies that decrease the production and trafficking of illegal drugs and related corruption and violence in Latin America to succeed.

This draft Appropriations Committee report will be attached to the 2022 fiscal year spending bill for the Department of State, Foreign Operations and Related Programs. It remains unclear when the measures will be considered and officially approved by the panel.

If the measure is enacted, it would allow Washington D.C. to legalize recreational cannabis sales. It would also encourage the development of technologies that can identify THC-impaired driving and request the federal government to reconsider policies that require employees be fired for marijuana use. In addition, the measure criticizes the current restrictive system for classifying drugs, which hinders scientific research on marijuana.

Rep. Alexandria Ocasio-Cortez introduced a similar amendment in the House’s version of the spending legislation, which was recently passed. The measure calls for banning the use of funds for aerial fumigation on illicit crops in Colombia. Aerial fumigation has been widely criticized by human rights and reform advocates.

The step taken by the Senate committee could trigger a rethink of the country’s drug policies and maybe even kick-start a process through which cannabis may be rescheduled federally, ending one of the biggest hurdles that the industry and its sector players, such as Hero Technologies Inc. (OTC: HENC), have had to navigate.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Continues to Position Itself as Multistate Operator in Cannabis Sector

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license approval for a newly constructed medical marijuana facility, which will allow HENC to move forward with its plans for cultivation of cannabis in Michigan,” reads a recent article. “In addition to its Michigan expansion plans, Hero Technologies is undertaking expansion in Colorado through its wholly owned subsidiary Mile High Green LLC… HENC is also planning to expand in Massachusetts through its wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: HighlyRelaxing.com under Highly Relaxing LLC and VeteranHempCo.com.”

To view the full article, visit https://cnw.fm/8F6gr

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Top IRS Official Reveals Cannabis Banking Reform Can Ease Tax Organization’s Work

Marijuana businesses have been unable to access financial services such as deposit accounts, cashless payments and loans since legal sales began in America. This is mostly due to the controversial plant’s classification as a Schedule I controlled drug, and it has had wide-ranging consequences on both cannabis businesses and federal authorities.

Players in the cannabis space are forced to transact on a cash-only basis, increasing their chances of robberies and making it difficult to account for and pay taxes. Furthermore, federal authorities, the IRS specifically, don’t often receive taxes that are due, and when they do, it is usually in large amounts of cash.

For quite a while, stakeholders, drug reform activists and lawmakers have urged federal authorities to allow cannabis businesses to access banking services. Recently, a top IRS official joined the growing number of figures that support banking services for America’s state-legal cannabis industry after she claimed that cannabis banking reform would ease the taxman’s work.

The IRS would like to get paid, IRS official Cassidy Collins said during an event hosted by UCLA’s Annual Tax Controversy Institute, and granting marijuana access to the banking system will be a big help. As it stands, marijuana presents a “special type of collection challenge” since the plant is federally outlawed and mostly stuck to cash-only payments that make it harder for the federal agency to receive taxes from cannabis businesses, Cassidy says.

She notes that the cash-only payment crisis can be attributed to two things: customers that are avoiding a paper trail that shows they purchased cannabis and banks that avoid working with cannabis businesses due to fear of reprisal by the federal government. Fortunately, lawmakers have introduced cannabis reform bills to give the industry access to banking services, and one of them has made headway.

Cassidy, a senior counsel in the IRS Office of Chief Counsel, says that while her views on cannabis banking may not represent the IRS’s or her own opinion, it would make the agency’s job of collecting taxes a lot easier. The Internal Revenue Service’s main objective, after all, is to collect taxes, and any legislation that eases the agency’s efforts is welcome.

Currently, cannabis business operators have to visit IRS tax assistance centers, which accept cash payments greater than $50,000. However, Cassidy notes that an operator will likely spend some time at the center because the federal employee has to check and double-check payments. The agency wants to work with companies in the cannabis space, regardless of the plant’s status with the federal government, to ensure it gets paid the taxes owed. Should lawmakers finally pass cannabis legislation, both cannabis companies and the IRS stand to benefit.

Cannabis banking reform will not only benefit the IRS but will also remove a major bottleneck faced by the entire marijuana industry, including sector players such as Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Tech Is Transforming the Marijuana Industry

Despite being one of the youngest sectors in the country, the United States’ state-legal cannabis industry has been dubbed the fastest growing industry in the country. Cannabis companies have generated billions of dollars in revenue in the few years cannabis has been legal, providing hundreds of thousands of job opportunities and filling state coffers with millions in cannabis tax revenue.

The industry is projected to undergo exponential growth in the next couple of years, pulling in a whopping $43 billion in legal cannabis sales by 2025. However, cannabis could not have gotten to where it is so far without technological advancements that have made cultivating and processing the plant a lot more efficient, and experts predict that technology will play a significant role in the industry’s growth.

Software-based technology will be especially critical to cannabis businesses moving forward. As it is, most players in the cannabis space cannot access financial services such as wireless payments and loans as the murky regulatory space has kept financial providers away. Fintech company KindTap is the first company to offer a credit payment option for businesses in the cannabis space, first launching in Massachusetts before going to other U.S. markets, including Florida, Maine, and New York by the end of the year.

KindTap provides revolving credit lines for upfront purchases and a credit payment system for businesses. Cathy Corby Iannuzzelli, an executive at KindTap, joined the fintech after she noticed cashless payments were virtually nonexistent in the cannabis industry while working for a client in Denver.

Compared to other industries, cannabis barely has a comprehensive regulatory structure and runs on a patchwork of state policies, and this often results in a pile of bureaucracy and paperwork, especially for multistate operators that have to keep track of different policies and requirements in different states. It will likely be some time before lawmakers federally decriminalize cannabis and finally fix the mess that is America’s cannabis industry, but in the meantime, companies have to adhere to current policies.

Simplifya, a Denver-based cannabis compliance software provider, has developed software that ensures cannabis businesses stay compliant amid a fragmented regulatory environment. The operational compliance software automates complex processes and boasts badge tracking, tailored reporting, SOPs and employee accountability features.

Springbig, a customer loyalty and text message communications provider, has developed a single source of truth customer relationship management (“CRM”) that acts as a database to record in store and online purchases. It can also capture key purchasing and behavioral data, integrate with existing dispensary POS and eCommerce systems seamlessly. These are just a few examples of the companies that have studied the market and developed software-based solutions for many of the issues that plague cannabis. As the industry becomes larger and draws more clientele, technology will be instrumental in achieving marijuana’s maximum potential.

Given the pace at which the industry is evolving, many cannabis companies, including Hero Technologies Inc. (OTC: HENC), are putting technology at the core of their operations in order to gain an edge over other sector actors.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Many Patients with Breast Cancer Use Marijuana Alongside Meds

Over the past couple of years, cannabis has grown increasingly popular as more states pass legislation to allow either medical marijuana or recreational cannabis. With advocates across the country advocating for state measures and lawmakers discussing federal decriminalization, cannabis has come a long way from the days of prohibition.

As it has slowly shed its unfounded reputation as a destructive drug, cannabis has interestingly moved into the health and wellness space thanks to a diverse range of purported health benefits. By May 2018, more than 3.5 million registered medical marijuana patients existed across the country, with countless more using recreational marijuana to try and alleviate their health issues.

However, despite cannabis’ popularity as a medical alternative, most scientists caution that the hype has far outpaced the science. While marijuana definitely has medical potential, using it as an alternative to pharmaceuticals, especially without the knowledge and permission of a doctor, can be quite dangerous. According to recently published research, such a situation is unfolding in America among individuals suffering from breast cancer. The study, which was published in “Cancer,” an American Cancer Society peer-reviewed journal, found that nearly half of American adults suffering from breast cancer use marijuana alongside their treatment to manage side effects and symptoms.

Various types of cancer and their treatments often cause pain, fatigue, insomnia, nausea and other health issues. Although studies have found that cannabis can indeed alleviate issues such as chronic pain, lack of appetite and insomnia, many physicians are not comfortable discussing it as a treatment option due to the limited knowledge on cannabis’ risks and benefits.

To find the rate of cannabis use among breast cancer patients, the researchers conducted an online survey of 612 participants. An estimated 42% of respondents said they had used cannabis to treat symptoms such as pain, insomnia, anxiety, nausea and vomiting with 75% of those who used cannabis reporting that it was extremely or very helpful.

Disturbingly, 49% of the participants who used marijuana believed medical cannabis could treat cancer, a claim that is still unproven by scientists. Almost 80% of the cannabis users had taken cannabis while undergoing other treatments such as surgery, radiation and systemic therapies. Half of those patients had looked for information on medical cannabis with websites and other patients being the most popular sources of information and physicians being the least popular. Most of the respondents were not satisfied with the information they received on medical cannabis. Furthermore, participants used cannabis products of varying quality and purity, mistakenly assuming that the products were safe and tested.

The researchers concluded that health providers ought to initiate informed conversations about medical marijuana with their patients. The fact that cancer patients are using cannabis without their doctors’ knowledge is a “major blind spot” in ability of health-care providers to provide suitable care, the researchers say. Initiating informed conversations will allow doctors to properly manage the symptoms and side effects of cancer and cancer treatment while minimizing potential side effects and treatment interactions.

The findings that plenty of women are using marijuana alongside their prescription medications seems to reaffirm how much the public has come to trust medicinal cannabis products such as those made by companies such Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Shows Lung Injuries Linked to Tainted Vapes Were Low in Legalized Cannabis Markets

In late 2019, the United States was rocked by an outbreak of severe lung illness that took 68 lives and left an estimated3,000 individuals with ill health. Authorities soon found out that the cause of this lung disease breakout was illegal black market cannabis vaping products containing vitamin E acetate, a synthetic form of vitamin E that was used as a thickening agent. Dubbed e-cigarette and vaping-associated lung injury (“EVALI”), the outbreak led to the pull-out of several cannabis products with artificial thickening agents such as vitamin E acetate. In addition, regulators are thinking of banning the use of such additives in cannabis products.

Now, a new federally funded study looking at the relationship between the prevalence of EVALI and state cannabis policies has revealed that the outbreak was significantly less severe in states with legal cannabis markets. Published in the “Drug and Alcohol Dependence” journal, the study found that EVALI was less prevalent in states where adult-use cannabis was legal or where medical marijuana patients were allowed to grow their own cannabis. States with recreational cannabis markets had 42% fewer EVALI cases, the National Institute on Drug Abuse-funded study revealed, while those that had medical marijuana markets where home cultivation was allowed had 60% lower EVALI incidence compared to medical marijuana states that didn’t allow home cultivation.

The report concluded that while there was a relationship between recreational marijuana laws and reduced EVALI incidence, the incidence of lung disease in medical marijuana states depended on “their policy attributes.” The states that had the highest EVALI incidence had either banned cannabis use outright or had medical cannabis industries that didn’t allow for home cultivation.

Penned by Abigail Friedman, a professor at Yale School of Public Health, and Megan Morean, a psychiatry research student at the Yale School of Medicine, the report is further proof of what cannabis reform activists have been saying: a legal cannabis market where products are regulated and tested for safety is much better than outright prohibition.

Outlawing cannabis will not reduce the demand; it will rather provide an avenue for black-market players to step in and provide products that are neither regulated nor tested for safety. And as we saw from the EVALI outbreak, it is the public that pays the ultimate price when there are no legal, registered sellers. As the report states, public demand for illicit products will decrease if consumers can obtain the substance legally from reputable sellers.

This research provides further proof that sector player such as Hero Technologies Inc. (OTC: HENC) aren’t only in business for profit but also indirectly protect public health.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.